Johns University College of Pharmacy & Health Sciences
doi: 10.3389/fphar.2024.1443794 Received 04 June 2024 Accepted 12 August 2024 Published 26 August 2024 Volume 15 - 2024 Edited by Yurong Lai, Gilead, United States Reviewed by Mamunur Rashid, University of Nebraska Medical Center, United States Sagnik Chatterjee, Ferring Pharmaceuticals, Denmark Peter Krajcsi, Consultant, Budapest, Hungary Updates Copyright 2024 Mao, Yu, Qin, She, Rong, Hu and Zhong
The FTO gene variant (rs9939609) also correlates with baseline appetite regulation, meaning your starting response to semaglutide tablets depends partly on whether your genetic background predisposes you to more or less hunger hormone sensitivity
As demand for GLP-1 treatments continues to climb, the outcome of these cases may influence both patent enforcement strategy and the marketing playbook for compounded drug sellers